FAGNX | VENAX | FAGNX / VENAX | |
Total Expense Ratio | 1.23 | 0.09 | 1,367% |
Annual Report Gross Expense Ratio | 1.23 | 0.09 | 1,367% |
Fund Existence | 38 years | 21 years | - |
Gain YTD | 8.038 | 3.715 | 216% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 944M | 9B | 10% |
Annual Yield % from dividends | 0.74 | 3.06 | 24% |
Returns for 1 year | 0.51 | -2.46 | -21% |
Returns for 3 years | 23.02 | 12.54 | 184% |
Returns for 5 years | 271.87 | 218.78 | 124% |
Returns for 10 years | 70.81 | 35.04 | 202% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LICAX | 18.30 | 0.06 | +0.33% |
Lord Abbett International Equity A | |||
GMVAX | 16.88 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
FMUCX | 15.56 | 0.03 | +0.19% |
Federated Hermes Muni and Stock Adv C | |||
VSTSX | 316.29 | 0.20 | +0.06% |
Vanguard Total Stock Mkt Idx Instl Sel | |||
SUWCX | 34.91 | 0.01 | +0.03% |
DWS Core Equity C |